New Alzheimer’s drug development uses AI, directed evolution, and fermentation.

  • 📰 PsychToday
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Ai Ai Headlines News

Ai Ai Latest News,Ai Ai Headlines

A new study shows how AI machine learning can help guide and improve enzyme design for the synthesis of medication to treat dementia and Alzheimer's disease.

A new study showed how AI machine learning can help improve enzyme design for the synthesis of galantamine.

Galantamine is a drug that may help improve the cognitive ability of patients diagnosed with dementia. machine learning can help guide and improve enzyme design for the synthesis of galantamine, a drug used to treat patients withand Alzheimer's disease. This study demonstrates the powerful potential of the combination of AI and directed evolution in the industrial-scale production of important medications in the future.

Galantamine may help improve the cognitive ability of patients diagnosed with dementia or Alzheimer’s by slowing the breakdown of acetylcholine, a neurotransmitter that plays a key role in learning andby Paul Francis. Galantamine, the generic drug for Razadyne™, Reminyl™, and Nivalin®, is a small molecule capable of crossing the blood-brain barrier that has been approved by the U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 714. in Aİ

Ai Ai Latest News, Ai Ai Headlines